Channel Wealth’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$359K Sell
7,490
-1,391
-16% -$59.8K 0.08% 131
2026
Q1
$326K Sell
8,881
-297
-3% -$14.1K 0.08% 132
2025
Q4
$467K Sell
9,178
-11,420
-55% -$584K 0.12% 99
2025
Q3
$1.14M Sell
20,598
-43,113
-68% -$2.52M 0.31% 60
2025
Q2
$4.4M Sell
63,711
-1,873
-3% -$127K 1.24% 24
2025
Q1
$4.55M Buy
65,584
+16,165
+33% +$1.34M 1.42% 20
2024
Q4
$4.25M Sell
49,419
-7,934
-14% -$858K 1.38% 20
2024
Q3
$6.83M Buy
57,353
+7,756
+16% +$1.03M 2.25% 10
2024
Q2
$7.08M Buy
49,597
+14,755
+42% +$1.96M 2.57% 7
2024
Q1
$4.47M Buy
34,842
+4,071
+13% +$485K 1.8% 13
2023
Q4
$3.18M Buy
30,771
+11,079
+56% +$1.1M 1.5% 18
2023
Q3
$1.79M Buy
19,692
+6,304
+47% +$555K 1% 30
2023
Q2
$1.08M Buy
13,388
+948
+8% +$77.4K 0.62% 60
2023
Q1
$990K Buy
+12,440
New +$882K 0.64% 46

Other funds holding NVO

Channel Wealth's NVO Position: Q2 2026 in Review

Channel Wealth reduced its Novo Nordisk (NVO) stake by 16% in Q2 2026, selling an estimated $59.8K and leaving 7,490 shares worth $359K. The position accounts for 0.08% of the portfolio, ranked #131.

Channel Wealth first reported a position in NVO in Q1 2023 and has held it in 14 quarters since. The position peaked at $7.08M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Channel Wealth held 7,490 shares of Novo Nordisk worth $359K as of Q2 2026.
  • Channel Wealth sold 1,391 Novo Nordisk shares in Q2 2026, an estimated $59.8K.
  • Novo Nordisk made up 0.08% of Channel Wealth's portfolio in Q2 2026, its #131 holding.
  • Channel Wealth first reported a position in Novo Nordisk in Q1 2023 and has held it in 14 quarters since.
  • Channel Wealth's Novo Nordisk position peaked at $7.08M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Channel Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.